Effects of glucosamine infusion on insulin secretion and insulin action in humans

Diabetes

Volumn 49, Issue 6, 2000, Pages 926-935

  Monauni, Tiziano ^a   Zenti, Maria Grazia ^a   Cretti, Anna ^a   Daniels, Marc C ^e   Targher, Giovanni ^a   Caruso, Beatrice ^b   Caputo, Marco ^b   McClain, Donald ^f   Del Prato, Stefano ^c   Giaccari, Andrea ^d   Muggeo, Michele ^a   Bonora, Enzo ^a   Bonadonna, Riccardo C ^a,g  

^a City Hospital of Verona   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^d Div of Gynecologic Endocrinology   (Italy)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE; GLUCOSE; HEXOSAMINE; INSULIN; SODIUM CHLORIDE;

ADULT; ARTICLE; CALORIMETRY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NORMAL HUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0034037064     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.6.926     Document Type: Article

References (70)

1. Unger RH, Grundy S: Hyperglycemia as an inducer as well as a consequence of impaired islet function and insulin resistance: implications for the management of diabetes. Diabetologia 28:119-121, 1985
2. Rossetti L, Giaccari A, DeFronzo RA: Glucose toxicity. Diabetes Care 13:610-630, 1990
3. Traxinger RR, Marshall S: Role of amino acids in modulating glucose-induced desensitization of the glucose transport system. J Biol Chem 35:20910-20916, 1989
4. Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712, 1991
5. Traxinger RR, Marshall S: Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine: role of hexosamine biosynthesis in enzyme regulation. J Biol Chem 266:10148-10154, 1991
6. Nerlich AG, Sauer U, Kolm Litty V, Wagner E, Koch M, Schleicher ED: Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes. Diabetes 47:170-178, 1998
7. Baron AD, Zhu JS, Zhu JH, Weldon H, Maianu L, Garvey WT. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle: implications for glucose toxicity. J Clin Invest 96:2792-2801, 1995
8. Cooksey RC, Hebert LF Jr, Zhu JH, Wofford P, Garvey WT, McClain DA: Mechanism of hexosamine-induced insulin resistance in transgenic mice over-expressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology 140:1151-1157, 1999
9. Robinson KA, Sens DA, Buse MG: Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscle: study of mechanisms in muscle and in rat-1 fibroblast over-expressing the human insulin receptor. Diabetes 42:1333-1346, 1993
10. Crook ED, Zhou J, Daniels M, Neidigh JL, McClain DA: Regulation of glycogen synthase by glucose, glucosamine, and glutamine:fructose-6-phosphate amidotransferase. Diabetes 44:314-320, 1995
11. Crook ED, McClain DA: Regulation of glycogen synthase and protein phosphatase-1 by hexosamines. Diabetes 45:322-327, 1996
12. Hresko RC, Heimberg H, Chi MM, Mueckler M: Glucosamine-induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP. J Biol Chem 273:20658-20668, 1998
13. Kim YB, Zhu JS, Zierath JR, Shen HQ, Baron AD, Kahn BB: Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Diabetes 48:310-320, 1999
14. Patti ME, Virkamaki A, Landaker EJ, Kahn CR, Yki-Jarvinen H: Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin-signaling events in skeletal muscle. Diabetes 48:1562-1571, 1999
15. Filippis A, Clark S, Proietto J: Increased flux through the hexosamine biosynthesis pathway inhibits glucose transport acutely by activation of protein kinase C. Biochem J 324:981-985, 1997
16. Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N: In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest 96:132-140, 1995
17. Giaccari A, Morviducci L, Zorretta D, Sbraccia P, Leonetti F, Caiola S, Buongiorno A, Bonadonna RC, Tamburrano G: In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat possible relevance to the maladaptive responses to chronic hyperglycemia. Diabetologia 38:518-524, 1995
18. Virkamaki A, Daniels MC, Hamalainen S, Utriainen T, McClain D, Yki-Jarvinen H: Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology 138:2501-2507, 1997
19. Hawkins M, Barzilai N, Chen W, Angelov I, Hu M, Cohen P, Rossetti L: Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes 45:1734-1743, 1996
20. Holmang A, Nilsson C, Niklasson M, Larsson BM, Lonroth P: Induction of insulin resistance by glucosamine reduces blood flow but not interstitial levels of either glucose or insulin. Diabetes 48:106-111, 1999
21. Hawkins M, Barzilai N, Liu R, Hu M, Chen W, Rossetti L: Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest 99:2173-2182, 1997
22. Buse MG, Robinson KA, Marshall BA, Mueckler M: Differential effects of GLUT1 or GLUT4 overexpression on hexosamine biosynthesis by muscles of transgenic mice. J Biol Chem 271:23197-23202, 1996
23. Hebert LF Jr, Daniels MC, Zhou J, Crook ED, Turner RL, Simmons ST, Neidigh JL, Zhu JS, Baron AD, McClain DA: Overexpression of glutamine:fructosp-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 98:930-936, 1996
24. McClain DA, Crook ED: Hexosamines and insulin resistance. Diabetes 45:1003-1009, 1996
25. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L: A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393:684-688, 1998
26. Shimabukuro M, Koyama K, Vhen G, Wang M-Y, Trieu F, Lee Y, Newgard CB, Unger RH: Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A 94:4637-4641, 1997
27. Robinson KA, Weinstein ML, Lindenmayer GE, Buse MG: Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes 44:1438-1446, 1995
28. Buse MG, Robinson KA, Gettys TW, McMahon EG, Gulve EA: Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice. Am J Physiol 272: E1080-E1088, 1997
29. Yki-Jarvinen H, Daniels MC, Virkamaki A, Makimattila S, DeFronzo RA, McClain D: Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM. Diabetes 45:302-307, 1996
30. Daniels MC, Ciaraldi TP, Nikoulina S, Henry RR, McClain DA: Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relatioaship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. J Clin Invest 97:1235-1241, 1996
31. Shepherd PR, Kahn BB: Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N Engl J Med 341:248-257, 1999
32. Miles PDG, Higo K, Romeo OR, Lee M-K, Rafaat K, Olefsky JO: Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance. Diabetes 47:395-400, 1998
33. Nelson BA, Robinson KA, Koning JS, Buse MG: Effects of exercise and feeding on the hexosamine biosynthetic pathway in rat skeletal muscle. Am J Physiol 272:E848-E855, 1997
34. Virkamaki A, Yki-Jarvinen H: Allosteric regulation of glycogen synthase and hexokinase by glucosamine-6-phosphate during glucosamine-induced insulin resistance in skeletal muscle and heart. Diabetes 48:1101-1107, 1999
35. Spiro RG: The effect of N-acetylglucosamine and glucosamine on carbohydrate metabolism in rat liver slices. J Biol Chem 233:546-550, 1958
36. Malaisse WJ, Lea MA, Malaisse-Lagae F: The effect of mannoheptulose on the phosphorylation of glucose and the secretion of insulin by islets of Langerhans. Metabolism 17:126-132, 1968
37. Balkan B, Dunning BE: Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats. Diabetes 43:1173-1179, 1994
38. Shankar RR, Zhu JS, Baron AD: Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus. Metabolism 47:573-577, 1998
39. Adams ME: Hype about glucosamine. Lancet 354:353-354, 1999
40. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
41. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
42. Perseghin G, Ghosh S, Gerow K, Shulman GI: Metabolic defects in lean non-diabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001-1009, 1997
43. Bonadonna RC, Del Prato S, Bonora E, Gulli G, Solini A, DeFronzo RA: Effects of physiological hyperinsulinemia on the intracellular metabolic partition of plasma glucose. Am J Physiol 265:E943-E953, 1993
44. Somogyi M: Determination of blood sugar. J Biol Chem 160:69-73, 1945
45. Bonadonna RC, Del Prato S, Saccomani MP, Bonora E, Gulli G, Ferrannini E, Bier D, Cobelli C, DeFronzo RA: Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest 92:486-494, 1993
46. Toffolo G, De Grandi F, Cobelli C: Estimation of β-cell sensitivity from intravenous glucose tolerance test C-peptide data: knowledge of the kinetics avoids errors in modeling the secretion. Diabetes 44:845-854, 1995
47. Vicini P, Caumo A, Cobelli C: The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity. Am J Physiol 273:E1024-E1032, 1997
48. Frayn KN: Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55:628-634, 1983
49. Zar J: Biostatistical Analysis. Englewood Cliffs, NJ, Prentice Hall, 1984
50. Matschinsky FM, Glaser B, Magnuson MA: Pancreatic β-cell glucokinase: closing the gap between theoretical concepts and experimental realities. Diabetes 47:307-315, 1998
51. Sturis J, Kurland IK, Byrne MM, Mosekilde E, Froguel P, Pilkis SJ, Bell GI, Polonsky KS: Compensation in pancreatic β-cell function in subjects with glucokinase mutations. Diabetes 43:718-723, 1994
52. Yki-Jarvinen H, Young AA, Lamkin C, Foley JE: Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 79:1713-1719, 1987
53. Kawano Y, Rincon J, Soler A, Ryder JW, Nolte LA, Zierath JR, Wallberg-Henriksson H: Changes in glucose transport and protein kinase Cβ2 in rat skeletal muscle induced by hyperglycaemia. Diabetologia 42:1071-1079, 1999
54. 12 myotubes and rat skeletal muscle. Diabetes 44:646-651, 1995
55. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effects of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000-1007, 1981
56. Saccà L, Orofino G, Petrone A, Vigorito C: Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance. J Clin Invest 73:1683-1687, 1984
57. Barzilai N, Hawkins M, Angelov I, Hu M, Rossetti L: Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production. Diabetes 45:1329-1335, 1996
58. Cadefau J, Bollen M, Stalmans W: Glucose-induced glycogenesis in the liver involves the glucose-6-phosphate-dependent dephosphorylation of glycogen synthase. Biochem J 322:745-750, 1997
59. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA: Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes 47:1735-1747, 1998
60. Del Prato S, Matsuda M, Simonson DC, Groop LC, Sheehan P, Leonetti F, Bonadonna RC, DeFronzo RA: Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia 40:687-697, 1997
61. Basu A, Caumo A, Bettini F, Gelisio A, Alzaid A, Cobelli C, Rizza RA: Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes 46:421-432, 1997
62. Avogaro A, Vicini P, Valerio A, Caumo A, Cobelli C: The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM. Am J Physiol 270:E532-E540, 1996
63. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J: Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32:35-45, 1983
64. Baron AD, Brechtel G, Wallace P, Edelman SV: Rates and tissues sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol 255: E769-E774, 1988
65. 13C-nuclear magnetic resonance. N Engl J Med 322:223-228, 1990
66. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM. In International Textbook of Diabetes Mellitus. 2nd ed. Alberti KGMM, DeFronzo RA, Zimmet P, Keen H, Eds. London, John Wiley and Sons, 1997, p. 635-712
67. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B: Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77:98-105, 1986
68. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
69. Caumo A, Cobelli C: Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model. Am J Physiol 264:E829-E841, 1993
70. Steil GM, Rebrin K, Mittelman SD, Bergman RN: Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. Diabetes 47:714-720, 1998